Qiagen stock after-hours at EUR 38.04: minus 1.73 percent versus prior close
Published on 10/01/2026 at 19:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Qiagen stock was at EUR 38.04 after-hours at 6:48 p.m. CEST on October 1, 2026, down EUR 0.67, or 1.73 percent, versus the prior close of EUR 38.71 at Lang & Schwarz.
Trading day
The quoted price was below the prior close at Lang & Schwarz. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Qiagen stock.
Recent product announcements
On September 28, 2026, QIAGEN Investor Relations reported that the FDA had cleared a new QIAstat-Dx bloodstream infection panel in the United States. The panel identifies 13 gram-negative bacterial targets and 18 antibiotic-resistance markers in about one hour. Together with a complementary panel, the portfolio covers 33 pathogen targets and 28 resistance markers.
On September 24, 2026, QIAGEN Investor Relations announced the launch of QIAmini, a compact automated system for small-batch sample preparation. The system processes up to eight samples per run, and QIAGEN said it reduced hands-on time by more than 80 percent across evaluated workflows.
